Los Angeles Capital Management’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$300K Buy
44,632
+16,840
+61% +$113K ﹤0.01% 1045
2025
Q1
$251K Sell
27,792
-240
-0.9% -$2.17K ﹤0.01% 948
2024
Q4
$485K Sell
28,032
-5,900
-17% -$102K ﹤0.01% 819
2024
Q3
$542K Buy
+33,932
New +$542K ﹤0.01% 843